文献速递肿瘤 PET/CT神经核医学

18F-FDG与68Ga-DOTATATE PET/CT显示转移性嗜铬细胞瘤与肺腺癌共存

Concurrent Metastatic Pheochromocytomas and Lung Adenocarcinoma on 18F-FDG and 68Ga-DOTATATE PET/CT Images.
PubMed 文献 · Clin Nucl Med · 2019-01-01

本文报告一例60岁男性复发性转移性嗜铬细胞瘤与肺腺癌共存患者的18F-FDG和68Ga-DOTATATE PET/CT表现。转移性嗜铬细胞瘤在两种显像中均显示活性增高,而肺腺癌病灶未见明显DOTATATE活性。

要点

  • 转移性嗜铬细胞瘤在18F-FDG和68Ga-DOTATATE PET/CT上均活性增高。
  • 肺腺癌病灶在68Ga-DOTATATE PET/CT上未见明显活性。
  • 双显像剂PET/CT有助于区分嗜铬细胞瘤转移与共存肿瘤。

核心结论

  • 复发性转移性嗜铬细胞瘤与肺腺癌共存时,转移性嗜铬细胞瘤在18F-FDG和68Ga-DOTATATE PET/CT上均活性增高,而肺腺癌病灶未见明显DOTATATE活性。

研究设计与样本

  • 病例报告:一例60岁男性复发性转移性嗜铬细胞瘤与肺腺癌共存患者,行18F-FDG和68Ga-DOTATATE PET/CT显像。

主要发现

  • 转移性嗜铬细胞瘤在18F-FDG和68Ga-DOTATATE PET/CT上均显示活性增高。
  • 肺腺癌病灶在68Ga-DOTATATE PET/CT上未见明显活性。

临床怎么用

  • 对嗜铬细胞瘤患者评估时,若18F-FDG与68Ga-DOTATATE PET/CT表现不一致,需考虑共存其他肿瘤的可能。

局限性

  • 本文为单例病例报告,结论的普遍适用性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Both F-FDG and Ga-DOTATATE PET/CT are used in the evaluation of pheochromocytomas. We reported F-FDG and Ga-DOTATATE PET/CT findings in a 60-year-old man who had recurrent metastatic pheochromocytoma coexisting with lung adenocarcinoma. The metastatic pheochromocytoma showed increased activity on both F-FDG and Ga-DOTATATE PET/CT, whereas the lung adenocarcinoma lesion showed no obvious DOTATATE activity.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Cheng Z, Zou S, Song S, et al. Concurrent Metastatic Pheochromocytomas and Lung Adenocarcinoma on 18F-FDG and 68Ga-DOTATATE PET/CT Images. Clin Nucl Med. 2019. PMID: 31021913. doi:10.1097/RLU.0000000000002588

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。